COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
HCQ ex vivo study
5/8 Ex Vivo
Grassin-Delyle et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaa546 (Peer Reviewed) (Ex Vivo) (not included in the study count)
Chloroquine Inhibits the Release of Inflammatory Cytokines by Human Lung Explants
Source   PDF   Share   Tweet
On human lung parenchymal explants, CQ concentration clinically achievable in the lung (100 µM) inhibited the lipopolysaccharide-induced release of TNF-ɑ (by 76%), IL-6 (by 68%), CCL2 (by 72%), and CCL3 (by 67%). In addition to antiviral activity, CQ may also mitigate the cytokine storm associated with severe pneumonia caused by coronaviruses.

Grassin-Delyle et al., 5/8/2020, peer-reviewed, 8 authors.
Details of all 260 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit